Nutshell Therapeutics
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biotech developing novel small molecule drugs for oncology and immunology using advanced computational design.
OncologyImmunology
Technology Platform
An integrated platform combining AI-driven computational chemistry, structural biology, and medicinal chemistry for the design of novel small molecule drugs.
Opportunities
Potential to discover first-in-class molecules for validated but difficult-to-drug targets in cancer and inflammation.
Risk Factors
High risk of preclinical failure and intense competition may challenge differentiation and commercial viability.
Competitive Landscape
Operates in the highly competitive small molecule oncology space, competing with both global pharma and numerous agile Chinese biotechs.